Abstract
Combining Clinical Parameters and Immunohistochemical Markers Might Strengthen Prediction of Recurrence of Non-Muscle Invasive Bladder Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have